… papillomavirus vaccine implementation, a major obstacle to human papillomavirus vaccination
is … 42s The main source of HPV vaccination program costs in developed countries is the …

… red circle - developed, blue square - developing), … developed countries and developing
countries, but the associations were weak (developed countries R 2 = 0.06; developing countries …

… several developing countries [24]. The financial cost burden is recognized, as many low and
lower-middle income countries receive financial assistance for HPV vaccine implementation …

… Most developed countries have already incorporated HPV vaccines into their national
immunization schedules. Adoption has been slower in developing countries, even though that is …

… Greater than 80% of those deaths occur in women living in developing countries, highlighting
… have failed to reduce substantially cervical cancer incidence in most developing countries. …

… Cervical cancer is the second-most common cancer in women worldwide causing most
cancer related deaths in women in developing countries including India. The most predominant …

… have declined dramatically in developed countries. According to many researchers, human
papillomavirus (HPV) infection has an important role in the development of cervical neoplasm…

… [13–16] based on efficacy of this vaccine against vaccine-type persistent infection and …
of these vaccines with expanding use into new settings, particularly less developed countries, …

… countries with universal HPV vaccination are in the developed world, some developing
countries … Global estimates of human papillomavirus vaccination coverage by region and income …

… VLP vaccines now in clinical trials will likely be too expensive for developing countries,
so alternative vaccines may have to be developed to reach these populations. …